4.5 Article

Sorting receptor SORLA - a trafficking path to avoid Alzheimer disease

Journal

JOURNAL OF CELL SCIENCE
Volume 126, Issue 13, Pages 2751-2760

Publisher

COMPANY BIOLOGISTS LTD
DOI: 10.1242/jcs.125393

Keywords

APP; Alzheimer disease; VPS10-domain receptors; Protein transport; Retromer

Categories

Funding

  1. Helmholtz-Association (HelMA) [HA-215]
  2. Fritz Thyssen Foundation [10.11.1.226]
  3. Alzheimer Research Initiative [AFI 11810]
  4. Lundbeck Foundation [R93-A8578]
  5. Novo Nordisk Foundation [R179-A15311]
  6. Augustinus Foundation [11-4408]
  7. Aase and Ejnar Danielsens Foundation
  8. Novo Nordisk Fonden [NNF11OC1015311] Funding Source: researchfish

Ask authors/readers for more resources

Excessive proteolytic breakdown of the amyloid precursor protein (APP) to neurotoxic amyloid beta peptides (A beta) by secretases in the brain is a molecular cause of Alzheimer disease (AD). According to current concepts, the complex route whereby APP moves between the secretory compartment, the cell surface and endosomes to encounter the various secretases determines its processing fate. However, the molecular mechanisms that control the intracellular trafficking of APP in neurons and their contribution to AD remain poorly understood. Here, we describe the functional elucidation of a new sorting receptor SORLA that emerges as a central regulator of trafficking and processing of APP. SORLA interacts with distinct sets of cytosolic adaptors for anterograde and retrograde movement of APP between the trans-Golgi network and early endosomes, thereby restricting delivery of the precursor to endocytic compartments that favor amyloidogenic breakdown. Defects in SORLA and its interacting adaptors result in transport defects and enhanced amyloidogenic processing of APP, and represent important risk factors for AD in patients. As discussed here, these findings uncovered a unique regulatory pathway for the control of neuronal protein transport, and provide clues as to why defects in this pathway cause neurodegenerative disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available